Suppr超能文献

脂蛋白肾小球病患者载脂蛋白 E2 仓敷突变(R158P)。

A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy.

机构信息

Division of Nephrology and Hypertension, Department of Internal Medicine, Kawasaki Medical School, Okayama, Japan.

出版信息

J Atheroscler Thromb. 2011;18(6):536-41. doi: 10.5551/jat.8102. Epub 2011 Apr 4.

Abstract

Lipoprotein glomerulopathy (LPG) is a rare glomerulopathy caused by lipoprotein thrombi. In almost all cases of LPG, several apolipoprotein (apo) E mutations were reported. Here, we present a case of LPG caused by a novel mutation that we named ApoE2 Kurashiki, which substitutes arginine with proline at apoE codon 158. ApoE2 polymorphism is well known for its relationship to type III hyperlipoproteinemia, and the common apoE2 isoform is encoded by the R158C allele. ApoE2 Kurashiki substitutes at the same codon and cannot be distinguished from common apoE2 by stan-dard apoE genotyping or phenotyping.

摘要

脂蛋白肾小球病 (LPG) 是一种由脂蛋白血栓引起的罕见肾小球病。在几乎所有的 LPG 病例中,都报告了几种载脂蛋白 (apo) E 突变。在这里,我们报告了一例由新突变引起的 LPG 病例,我们将其命名为 ApoE2 Kurashiki,该突变在 apoE 密码子 158 处将精氨酸替换为脯氨酸。apoE2 多态性与 III 型高脂蛋白血症密切相关,常见的 apoE2 同工型由 R158C 等位基因编码。ApoE2 Kurashiki 在同一密码子处替换,不能通过标准 apoE 基因分型或表型鉴定与常见的 apoE2 区分开来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验